HU179164B
(en)
*
|
1979-12-14 |
1982-08-28 |
Egyt Gyogyszervegyeszeti Gyar |
Process for producing cycloalkyl-ethers of alkanolamines
|
EP0084190A3
(en)
*
|
1981-12-08 |
1984-11-28 |
Fisons Plc |
Medicinal composition, package and method of making the composition
|
JPS58135805A
(ja)
*
|
1982-02-08 |
1983-08-12 |
Teijin Ltd |
アレルギー性鼻炎治療又は予防剤
|
JPS59163313A
(ja)
*
|
1983-03-09 |
1984-09-14 |
Teijin Ltd |
経鼻投与用ペプチドホルモン類組成物
|
GB8514090D0
(en)
*
|
1985-06-04 |
1985-07-10 |
Sandoz Ltd |
Organic compounds
|
US4576646A
(en)
*
|
1983-07-06 |
1986-03-18 |
Seppic |
Film-forming compositions for enveloping solid forms, particularly pharmaceutical or food products or seeds, and products obtained, coated with said compositions
|
EP0187433B1
(de)
*
|
1983-08-01 |
1990-12-27 |
Teijin Limited |
Pulverige pharmazeutische Zusammensetzung zur Anwendung auf die Schleimhaut der Mund- oder Nasenhöhle
|
JPS6032714A
(ja)
*
|
1983-08-01 |
1985-02-19 |
Teijin Ltd |
鼻腔粘膜に適用するための安定化された粉末状薬学的組成物
|
JPS61194034A
(ja)
*
|
1985-02-25 |
1986-08-28 |
Teijin Ltd |
経鼻投与用粉末状組成物
|
IT1187743B
(it)
*
|
1985-09-26 |
1987-12-23 |
Prodotti Formenti Srl |
Composizioni farmaceutiche a base di destrorfano per applicazione instranasale
|
US4847091A
(en)
*
|
1985-11-29 |
1989-07-11 |
Fisons Plc |
Pharmaceutical composition including sodium cromoglycate
|
GB8618259D0
(en)
*
|
1986-07-25 |
1986-09-03 |
Leo Pharm Prod Ltd |
Pharmaceutical compositions
|
DE3726517A1
(de)
*
|
1986-08-18 |
1988-03-03 |
Sandoz Ag |
Nasale zusammensetzungen, welche octreotid enthalten
|
US4767612A
(en)
*
|
1987-01-23 |
1988-08-30 |
Rorer Pharmaceutical Corporation |
Triamcinolone acetonide for the treatment of allergic rhinitis
|
US5112804A
(en)
*
|
1987-04-01 |
1992-05-12 |
Temple University Of The Commonwealth System Of Higher Education |
Pharmaceutical composition and method of intranasal administration
|
US5059587A
(en)
*
|
1987-08-03 |
1991-10-22 |
Toyo Jozo Company, Ltd. |
Physiologically active peptide composition for nasal administration
|
GB8723846D0
(en)
*
|
1987-10-10 |
1987-11-11 |
Danbiosyst Ltd |
Bioadhesive microsphere drug delivery system
|
EP0327756B1
(de)
*
|
1987-11-13 |
1994-01-26 |
Smithkline Beecham Farmaceutici S.p.A. |
Ein Calcitonin sowie ein Glycyrrhizinat als Absorptionsförderer enthaltende Arzneimittel
|
US5554388A
(en)
*
|
1989-02-25 |
1996-09-10 |
Danbiosyst Uk Limited |
Systemic drug delivery compositions comprising a polycationi substance
|
IT8920486A0
(it)
*
|
1989-05-12 |
1989-05-12 |
Isf Spa |
Composizioni farmaceutiche.
|
US5776493A
(en)
*
|
1989-07-14 |
1998-07-07 |
Alza Corporation |
Oral osmotic device for delivery of nystatin with hydrogel driving member
|
GB2237510B
(en)
*
|
1989-11-04 |
1993-09-15 |
Danbiosyst Uk |
Small particle drug compositions for nasal administration
|
US5707644A
(en)
*
|
1989-11-04 |
1998-01-13 |
Danbiosyst Uk Limited |
Small particle compositions for intranasal drug delivery
|
JP2549935B2
(ja)
*
|
1990-05-29 |
1996-10-30 |
三菱電機株式会社 |
信号処理装置
|
NL9002008A
(nl)
|
1990-09-12 |
1992-04-01 |
Stichting Centr Diergeneeskund |
Recombinant dna en rna en daarvan afgeleide produkten.
|
US5248310A
(en)
*
|
1992-03-27 |
1993-09-28 |
Alza Corporation |
Oral osmotic device with hydrogel driving member
|
US5512299A
(en)
*
|
1992-03-30 |
1996-04-30 |
Alza Corporation |
Method of treating oral inflammatory disease
|
DE69222295T2
(de)
*
|
1992-05-26 |
1998-04-09 |
Procter & Gamble |
Pulverförmige pharmazeutische Zusammensetzung
|
ES2159524T3
(es)
*
|
1992-06-12 |
2001-10-16 |
Teijin Ltd |
Preparacion farmaceutica para administrarse en el interior de las vias respiratorias.
|
ATE222754T1
(de)
*
|
1992-06-12 |
2002-09-15 |
Teijin Ltd |
Ultrafeines pulver zur inhalation und dessen herstellung
|
US6509006B1
(en)
|
1992-07-08 |
2003-01-21 |
Inhale Therapeutic Systems, Inc. |
Devices compositions and methods for the pulmonary delivery of aerosolized medicaments
|
US6582728B1
(en)
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
US5573776A
(en)
*
|
1992-12-02 |
1996-11-12 |
Alza Corporation |
Oral osmotic device with hydrogel driving member
|
US6024090A
(en)
|
1993-01-29 |
2000-02-15 |
Aradigm Corporation |
Method of treating a diabetic patient by aerosolized administration of insulin lispro
|
US7448375B2
(en)
|
1993-01-29 |
2008-11-11 |
Aradigm Corporation |
Method of treating diabetes mellitus in a patient
|
US5747445A
(en)
*
|
1993-06-24 |
1998-05-05 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
US6794357B1
(en)
|
1993-06-24 |
2004-09-21 |
Astrazeneca Ab |
Compositions for inhalation
|
TW402506B
(en)
|
1993-06-24 |
2000-08-21 |
Astra Ab |
Therapeutic preparation for inhalation
|
IS1796B
(is)
*
|
1993-06-24 |
2001-12-31 |
Ab Astra |
Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
|
US6632456B1
(en)
|
1993-06-24 |
2003-10-14 |
Astrazeneca Ab |
Compositions for inhalation
|
US5830853A
(en)
|
1994-06-23 |
1998-11-03 |
Astra Aktiebolag |
Systemic administration of a therapeutic preparation
|
US6051256A
(en)
*
|
1994-03-07 |
2000-04-18 |
Inhale Therapeutic Systems |
Dispersible macromolecule compositions and methods for their preparation and use
|
EP1462096B1
(de)
|
1994-03-07 |
2008-12-10 |
Nektar Therapeutics |
Verfahren und Zusammensetzung für die pulmonale Darreichung von Insulin
|
US6165976A
(en)
|
1994-06-23 |
2000-12-26 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
SK81197A3
(en)
|
1994-12-22 |
1997-11-05 |
Astra Ab |
Aerosol drug formulations, method for production thereof and its use
|
AU703532B2
(en)
|
1994-12-22 |
1999-03-25 |
Astra Aktiebolag |
Therapeutic preparation for inhalation containing parathyroid hormone, PTH
|
US6524557B1
(en)
|
1994-12-22 |
2003-02-25 |
Astrazeneca Ab |
Aerosol formulations of peptides and proteins
|
SE9404468D0
(sv)
*
|
1994-12-22 |
1994-12-22 |
Astra Ab |
Powder formulations
|
US5780014A
(en)
*
|
1995-04-14 |
1998-07-14 |
Inhale Therapeutic Systems |
Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
|
US6428771B1
(en)
*
|
1995-05-15 |
2002-08-06 |
Pharmaceutical Discovery Corporation |
Method for drug delivery to the pulmonary system
|
US5879712A
(en)
*
|
1995-06-07 |
1999-03-09 |
Sri International |
Method for producing drug-loaded microparticles and an ICAM-1 dosage form so produced
|
WO1997031626A1
(fr)
*
|
1996-02-27 |
1997-09-04 |
Teijin Limited |
Composition pulverulente destinee a une adminstration nasale
|
US5976573A
(en)
*
|
1996-07-03 |
1999-11-02 |
Rorer Pharmaceutical Products Inc. |
Aqueous-based pharmaceutical composition
|
US20030203036A1
(en)
|
2000-03-17 |
2003-10-30 |
Gordon Marc S. |
Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
|
WO1998029141A1
(en)
|
1996-12-31 |
1998-07-09 |
Inhale Therapeutic Systems, Inc. |
Processes for spray drying solutions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes
|
GB9700624D0
(en)
|
1997-01-14 |
1997-03-05 |
Danbiosyst Uk |
Drug delivery composition
|
GB9703673D0
(en)
*
|
1997-02-21 |
1997-04-09 |
Bradford Particle Design Ltd |
Method and apparatus for the formation of particles
|
EP1143896B1
(de)
|
1998-10-20 |
2006-12-13 |
The University of North Carolina at Chapel Hill |
Methoden zum befeuchten der nasenschleimhaut
|
JP2003501404A
(ja)
|
1999-06-04 |
2003-01-14 |
デルルックス ファーマシューティカル コーポレイション |
薬剤の脱水粒子からなる製剤およびこれの調製方法
|
DK1196430T3
(da)
*
|
1999-06-29 |
2012-05-21 |
Mannkind Corp |
Rensning og stabilisering af peptider og proteiner i farmaceutiske midler
|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
US6787164B2
(en)
*
|
2000-02-23 |
2004-09-07 |
Bioselect Innovations, Inc. |
Composition and method for treating the effects of diseases and maladies
|
US7575761B2
(en)
|
2000-06-30 |
2009-08-18 |
Novartis Pharma Ag |
Spray drying process control of drying kinetics
|
GB0027357D0
(en)
*
|
2000-11-09 |
2000-12-27 |
Bradford Particle Design Plc |
Particle formation methods and their products
|
GB0208742D0
(en)
|
2002-04-17 |
2002-05-29 |
Bradford Particle Design Ltd |
Particulate materials
|
FR2832311B1
(fr)
*
|
2001-11-21 |
2004-04-16 |
Besins Int Belgique |
Poudre filmogene, compositions la comprenant, leurs procedes de preparation et leurs utilisations
|
US6858615B2
(en)
|
2002-02-19 |
2005-02-22 |
Parion Sciences, Inc. |
Phenyl guanidine sodium channel blockers
|
DE60318938T2
(de)
|
2002-03-20 |
2009-01-22 |
Mannkind Corp., Valencia |
Inhalationsgerät
|
US7582284B2
(en)
|
2002-04-17 |
2009-09-01 |
Nektar Therapeutics |
Particulate materials
|
GB0216562D0
(en)
|
2002-04-25 |
2002-08-28 |
Bradford Particle Design Ltd |
Particulate materials
|
US9339459B2
(en)
|
2003-04-24 |
2016-05-17 |
Nektar Therapeutics |
Particulate materials
|
JP3691459B2
(ja)
*
|
2002-06-14 |
2005-09-07 |
久光メディカル株式会社 |
粉末状吸入剤組成物
|
DK1663235T3
(da)
|
2003-08-18 |
2013-10-28 |
Parion Sciences Inc |
Beskyttede pyrazinoylguanidin-natriumkanal-blokkere
|
US7745442B2
(en)
|
2003-08-20 |
2010-06-29 |
Parion Sciences, Inc. |
Methods of reducing risk of infection from pathogens
|
US7338171B2
(en)
*
|
2003-10-27 |
2008-03-04 |
Jen-Chuen Hsieh |
Method and apparatus for visual drive control
|
WO2005067964A1
(en)
*
|
2004-01-12 |
2005-07-28 |
Mannkind Corporation |
A method of reducing serum proinsulin levels in type 2 diabetics
|
US20050192264A1
(en)
*
|
2004-02-04 |
2005-09-01 |
Penfold Philip L. |
Slow release steroid composition
|
US20080248999A1
(en)
*
|
2007-04-04 |
2008-10-09 |
Biodel Inc. |
Amylin formulations
|
US20080090753A1
(en)
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
ES2385934T3
(es)
|
2004-08-20 |
2012-08-03 |
Mannkind Corporation |
Catálisis de la síntesis de dicetopiperazina.
|
EP2314298B1
(de)
|
2004-08-23 |
2015-05-27 |
MannKind Corporation |
Mikropartikel enthaltend Diketopiperazinsalze zur Arzneimitteldarreichung
|
CN101291689B
(zh)
*
|
2005-09-01 |
2012-12-05 |
若泽·路易斯·努诺·阿雅拉 |
用于大规模接种系统的活抗原的疫苗稳定化制剂
|
KR20160022404A
(ko)
|
2005-09-14 |
2016-02-29 |
맨카인드 코포레이션 |
활성제에 대한 결정질 미립자 표면의 친화력의 증가를 기반으로 하는 약물 제제화의 방법
|
US7713929B2
(en)
|
2006-04-12 |
2010-05-11 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US8084420B2
(en)
|
2005-09-29 |
2011-12-27 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
WO2007041481A1
(en)
*
|
2005-09-29 |
2007-04-12 |
Biodel, Inc. |
Rapid acting and prolonged acting insulin preparations
|
MX2008010721A
(es)
|
2006-02-22 |
2008-09-01 |
Mannkind Corp |
Un metodo para mejorar las propiedades farmaceuticas de microparticulas que contienen dicetopiperazina y un agente activo.
|
AU2007238114B2
(en)
|
2006-04-12 |
2010-10-14 |
Biodel, Inc. |
Rapid acting and long acting insulin combination formulations
|
AU2008214205B2
(en)
|
2007-02-11 |
2014-04-24 |
Map Pharmaceuticals, Inc. |
Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
|
JP5611844B2
(ja)
|
2008-02-26 |
2014-10-22 |
パリオン・サイエンシィズ・インコーポレーテッド |
多環芳香族ナトリウムチャネル遮断薬
|
US20090220386A1
(en)
*
|
2008-02-29 |
2009-09-03 |
Ferri Joseph E |
Porous Sealing Material
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
EP3281663B8
(de)
|
2008-06-13 |
2022-09-21 |
MannKind Corporation |
Atemluftbetriebener trockenpulverinhalator zur verabreichung von medikamenten
|
MX2010014240A
(es)
|
2008-06-20 |
2011-03-25 |
Mankind Corp |
Un metodo y aparato interactivo para perfilar en tiempo real esfuerzos de inhalacion.
|
TWI614024B
(zh)
|
2008-08-11 |
2018-02-11 |
曼凱公司 |
超快起作用胰島素之用途
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
US9060927B2
(en)
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
CA2754595C
(en)
|
2009-03-11 |
2017-06-27 |
Mannkind Corporation |
Apparatus, system and method for measuring resistance of an inhaler
|
US8551528B2
(en)
|
2009-06-12 |
2013-10-08 |
Mannkind Corporation |
Diketopiperazine microparticles with defined specific surface areas
|
EP2496295A1
(de)
|
2009-11-03 |
2012-09-12 |
MannKind Corporation |
Vorrichtung und verfahren zur simulation von einatmungsanstrengungen
|
BR112012033060A2
(pt)
|
2010-06-21 |
2018-02-27 |
Mannkind Corp |
métodos de sistema de liberação de fármaco em pó seco
|
MX350838B
(es)
|
2011-02-11 |
2017-09-18 |
Grain Proc Corporation * |
Composicion de sal.
|
KR101940832B1
(ko)
|
2011-04-01 |
2019-01-21 |
맨카인드 코포레이션 |
의약 카트리지용 블리스터 패키지
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
WO2013003444A1
(en)
|
2011-06-27 |
2013-01-03 |
Michael Ross Johnson |
A chemically and metabolically stable dipeptide possessing potent sodium channel blocker activity
|
AR086745A1
(es)
|
2011-06-27 |
2014-01-22 |
Parion Sciences Inc |
3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
|
EP2776053A1
(de)
|
2011-10-24 |
2014-09-17 |
MannKind Corporation |
Verfahren und zusammensetzungen zur schmerzbehandlung
|
JP6267135B2
(ja)
*
|
2012-02-10 |
2018-01-24 |
ダウ グローバル テクノロジーズ エルエルシー |
特定の中央粒子長のセルロース誘導体を含む、押出し成型セラミック体のための組成物
|
SG11201500218VA
(en)
|
2012-07-12 |
2015-03-30 |
Mannkind Corp |
Dry powder drug delivery systems and methods
|
EP2911690A1
(de)
|
2012-10-26 |
2015-09-02 |
MannKind Corporation |
Inhalierbare influenza-impfstoffzusammensetzungen und verfahren
|
NZ709197A
(en)
|
2012-12-17 |
2020-06-26 |
Parion Sciences Inc |
3,5-diamino-6-chloro-n-(n-(4-phenylbutyl)carbamimidoyl) pyrazine-2- carboxamide compounds
|
MX2015007796A
(es)
|
2012-12-17 |
2015-09-04 |
Parion Sciences Inc |
Derivados de cloro-pirazin carboxamida con actividad bloqueadora sobre los canales de sodio epiteliales.
|
EP3587404B1
(de)
|
2013-03-15 |
2022-07-13 |
MannKind Corporation |
Mikrokristalline diketopiperazinzusammensetzungen, verfahren zur herstellung und deren verwendung
|
US9937258B2
(en)
|
2013-07-17 |
2018-04-10 |
Dow Global Technologies Llc |
Composition for application to a nasal mucosa comprising a methylcellulose
|
BR122019026637B1
(pt)
|
2013-07-18 |
2023-09-26 |
Mannkind Corporation |
Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco
|
CA2920488C
(en)
|
2013-08-05 |
2022-04-26 |
Mannkind Corporation |
Insufflation apparatus and methods
|
BR112016004990B1
(pt)
|
2013-09-25 |
2022-10-11 |
Nutrition & Biosciences Usa 1, Llc |
Composição para aplicação em uma mucosa e recipiente
|
US9102633B2
(en)
|
2013-12-13 |
2015-08-11 |
Parion Sciences, Inc. |
Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds
|
WO2015148905A1
(en)
|
2014-03-28 |
2015-10-01 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
GB201410250D0
(en)
*
|
2014-06-10 |
2014-07-23 |
Nasaleze Patents Ltd |
Improvements to nasal compositions and method of use thereof
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|